Cardiovascular disease, commonly abbreviated as CV disease or CVD, is a broad term covering conditions that affect the heart and blood vessels. It has been the leading cause of death worldwide for more than three decades, accounting for roughly one in three deaths globally, with 20.5 million lives lost in 2021 alone.1PubMed Central. The Heart of the World The umbrella includes coronary artery disease, stroke, heart failure, peripheral artery disease, and rhythm disorders, among others. Most of these conditions share a common underlying process, and understanding that process is the key to understanding why CVD is so widespread and what you can do about it.
The Process Behind Most Cardiovascular Disease
The engine driving the majority of CVD is atherosclerosis, a slow buildup of fatty deposits, inflammatory cells, and scar tissue inside artery walls. It starts when the inner lining of an artery becomes irritated or damaged. Cholesterol-carrying particles seep into the artery wall, triggering an immune response. White blood cells move in to clean up the cholesterol, but many of them become engorged and die, forming a fatty, inflamed core within the vessel wall.2PubMed Central. Pathophysiology of Atherosclerosis Over years, fibrous tissue and calcium accumulate on top of that core, gradually narrowing the artery and stiffening it.3PubMed. Mechanisms of plaque formation and rupture
The danger is not only the narrowing. A plaque can crack open, exposing its contents to the bloodstream. The body responds by forming a blood clot on the spot, which can partially or completely block blood flow in seconds. This is why a person can feel fine one day and have a heart attack or stroke the next. The plaque may have been sitting quietly for decades before it ruptured.
Major Types of Cardiovascular Disease
CVD is not a single illness. The term covers a family of conditions, and they differ in which part of the circulatory system is affected and how the damage plays out.
Coronary Artery Disease
Coronary artery disease (CAD) involves the arteries that supply blood to the heart muscle itself. When those arteries narrow from plaque buildup, the heart muscle may not get enough oxygen during physical activity, causing chest pain known as stable angina. When a plaque ruptures and a clot forms, the result is an acute coronary syndrome, which includes unstable angina and heart attack.4PubMed. The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction CAD is the single deadliest form of CVD worldwide.
Stroke and Cerebrovascular Disease
Stroke occurs when blood flow to part of the brain is interrupted. The two main categories are ischemic stroke, caused by a clot blocking a brain artery, and hemorrhagic stroke, caused by a blood vessel in the brain leaking or bursting.5PubMed Central. The cerebral circulation and cerebrovascular disease III: Stroke Ischemic strokes account for the large majority of cases. Hemorrhagic strokes are less common but tend to be more immediately deadly; one study found that early mortality within 30 days was substantially higher with hemorrhagic stroke than ischemic stroke.6PubMed. Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke Together, ischemic heart disease and stroke accounted for about 85% of all CVD-related deaths in 2019.1PubMed Central. The Heart of the World
Heart Failure
Heart failure does not mean the heart has stopped. It means the heart can no longer pump blood efficiently enough to meet the body’s needs. It can develop after a heart attack damages the muscle, or it can result from years of high blood pressure, valve disease, or other conditions. About half of heart failure cases involve a weakened pump (reduced pumping strength), while the other half involve a stiffened heart that cannot relax and fill properly. The proportion of patients with the stiffening form has been increasing over time, likely reflecting the aging population and rising rates of high blood pressure, diabetes, and irregular heart rhythms.7PubMed Central. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
Peripheral Artery Disease and Arrhythmias
Peripheral artery disease (PAD) affects arteries outside the heart and brain, most commonly in the legs. Narrowed leg arteries cause cramping or pain during walking that eases with rest. PAD is a red flag for widespread atherosclerosis: people with it face a roughly 40% higher risk of dying from any cause and about 60% higher risk of dying from cardiovascular causes compared to people without it who have similar heart-rhythm problems.8PubMed Central. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta‐analysis PAD also appears to roughly double the risk of developing atrial fibrillation, the most common serious heart-rhythm disorder.9PubMed Central. Coronary Heart Disease Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: The Multi-Ethnic Study of Atherosclerosis However, much of that link may be explained by shared risk factors rather than a direct cause-and-effect relationship between PAD and atrial fibrillation.10PubMed Central. Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study
Symptoms and Warning Signs
One of the most frustrating things about CVD is that it can progress silently for years. Atherosclerosis can narrow arteries by half or more before you notice anything. When symptoms do appear, what you feel depends on which arteries are affected.
The classic heart-attack warning is chest pain or pressure, often described as tightness or heavy discomfort that may radiate to the back, arm, or jaw. It tends to come on gradually in intensity, occurs at rest or with minimal effort, and is frequently accompanied by sweating.11PubMed Central. Characterizing chest pain in patients with acute coronary syndrome at Vietnam National Heart Institute: a case-control study Heart failure tends to announce itself through breathlessness, fatigue, and swelling in the legs and feet. Stroke symptoms come on suddenly: weakness or numbness on one side of the body, difficulty speaking, vision changes, or a severe headache. PAD usually shows up as leg pain when walking that goes away with rest.
Not everyone gets the textbook symptoms, though, and that matters for getting timely treatment.
Why Women Often Present Differently
Heart attacks in women have historically been described as “atypical,” but the label is misleading. A large meta-analysis found that chest pain is actually the most common symptom for both sexes during an acute coronary event, showing up in about 79% of men and 74% of women.12PubMed Central. Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta-analysis The difference is that women are more likely to also experience nausea or vomiting, shortness of breath, and pain between the shoulder blades. Women had about twice the odds of reporting pain between the shoulder blades compared to men, and roughly 60% higher odds of nausea or vomiting.12PubMed Central. Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta-analysis
Women also tend to experience warning signs in the days before a heart attack, including unusual fatigue, and they often wait longer before going to a hospital after symptoms start.13PubMed Central. Myocardial Infarction Signs and Symptoms: Females vs. Males The researchers behind that meta-analysis argued that labeling any symptom as “atypical” is outdated, because the differences between sexes have been documented for years and there is considerable overlap. A better approach is to treat the full range of symptoms as normal presentations of heart disease, regardless of sex.
Risk Factors You Can Control
The biggest modifiable contributors to CVD are high blood pressure, unhealthy cholesterol levels, diabetes and insulin resistance, smoking, physical inactivity, and poor diet. These factors do not act in isolation. They reinforce each other, and their combined effect on your arteries accumulates over time.
Blood Pressure and Cholesterol
High blood pressure physically stresses artery walls, and elevated LDL cholesterol provides the raw material for plaque formation. These two risk factors are more dangerous in combination than either alone. Research has shown that elevated LDL cholesterol is associated with thicker artery walls in people with high blood pressure but not in those with lower blood pressure, consistent with the idea that blood-pressure-related damage makes artery walls more vulnerable to cholesterol infiltration.14PubMed. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the “response to injury” hypothesis of atherosclerosis
Duration of exposure matters, too. Long-term exposure to even moderately elevated LDL cholesterol and blood pressure can produce the same coronary heart disease risk as shorter exposure to levels doctors would flag as “high.” For example, 16 years of moderately elevated LDL produced a similar risk to 4 years of very high LDL.15PLoS ONE. Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease This is why managing these numbers earlier in life, not just after they cross a clinical threshold, can make a meaningful difference.
Insulin Resistance and Diabetes
Insulin resistance, where the body’s cells respond poorly to the hormone insulin, sets off a cascade of metabolic problems including unhealthy cholesterol ratios, chronic low-grade inflammation, and blood-vessel stiffness.16PubMed Central. Insulin resistance and cardiovascular disease You do not need to have diabetes for this to matter. Insulin resistance is common in people who appear otherwise healthy and is associated with several abnormalities that significantly raise the risk of coronary heart disease even without a diabetes diagnosis.17PubMed. Insulin resistance and coronary heart disease in nondiabetic individuals One proposed explanation for why insulin resistance, prediabetes, and overt diabetes all raise cardiovascular risk is oxidative stress, a state in which damaging molecules outpace the body’s ability to neutralize them, injuring blood vessel linings and promoting plaque growth.18PubMed. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
Smoking, Inactivity, and Diet
Cigarette smoke delivers a cocktail of stable chemicals that reach the blood vessels even though the initial exposure is in the lungs. These chemicals promote oxidative stress and alter how blood vessels regulate their own tone and metabolism. Sedentary behavior and a poor diet do something surprisingly similar at the cellular level, reprogramming how vascular cells handle energy and pushing them toward inflammation and stiffness.19PubMed Central. Pathological mechanisms of cigarette smoking, dietary, and sedentary lifestyle risks in vascular dysfunction: mitochondria as a common target of risk factors The converging end point of all three habits is a blood vessel lining that works less well, tighter arteries, and a greater tendency toward inflammation. This is why the standard lifestyle advice for heart health hits the same notes regardless of which specific risk factor you are targeting.
Risk Factors You Cannot Change
Age and sex are the two most powerful non-modifiable risk factors. CVD risk rises steeply with age as arteries gradually stiffen, the heart muscle thickens, and decades of risk-factor exposure take a cumulative toll.
Sex shapes cardiovascular risk in ways that shift across the lifespan. From childhood, males and females show differences in heart and blood vessel structure that track along distinct paths influenced by genetics and hormones.20PubMed Central. Sex Differences in Myocardial and Vascular Aging Men tend to develop coronary artery disease and have heart attacks earlier in life. Women’s risk rises more steeply after menopause, partly because their cholesterol profile worsens. While middle-aged men generally have higher LDL cholesterol than women of the same age, this reverses after about age 50, when women’s lipid levels tend to surpass men’s.21PubMed Central. Age-dependent sex differences in cardiometabolic risk factors Interestingly, the shift in women’s lipid levels begins gradually between ages 35 and 55, well before the traditional cutoff for menopause.
Women also appear to experience greater age-related heart wall thickening and stiffening, and coupled with stiffer blood vessels, postmenopausal women face steeper declines in the heart’s ability to relax and fill with blood between beats.22PubMed Central. Sex Differences in Cardiovascular Aging and Heart Failure This helps explain why the stiffening form of heart failure is more common in older women.
Family history also matters. Genetic risk scores can predict who is more likely to develop coronary artery calcium buildup, a marker of atherosclerosis, and this association persists even in adults over 75 after accounting for lifestyle and traditional risk factors.23PubMed Central. Polygenic Risk Scores and Extreme Coronary Artery Calcium Phenotypes (CAC=0 and CAC≥1000) in Adults ≥75 Years Old: The ARIC Study That said, a direct imaging measurement of coronary artery calcium, obtained through a low-dose CT scan, outperforms genetic risk scores for predicting actual coronary events. When both tools were tested, calcium scoring improved risk prediction beyond traditional risk factors, while the genetic score added no meaningful improvement on top of the calcium score.24JAMA. Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events
Newer Risk Factors Getting Attention
Chronic Inflammation
Inflammation is not just a bystander in atherosclerosis; it is an active driver. One way doctors measure it is with high-sensitivity C-reactive protein (hs-CRP), a blood marker of low-grade, ongoing inflammation. Elevated hs-CRP predicts cardiovascular events including heart attack and stroke, even in people with no prior heart disease, and it adds prognostic information beyond what traditional risk factors alone provide.25PubMed. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit Elevated CRP levels have also been linked to the development and progression of heart failure, reinforcing the idea that inflammation is involved in multiple branches of CVD, not just plaque-related events.26PubMed Central. The relation between C-reactive protein (CRP) and risk of incident heart failure in patients with cardiovascular disease: a narrative review
Sleep Apnea
Obstructive sleep apnea, in which the airway repeatedly collapses during sleep, is increasingly recognized as an independent cardiovascular risk factor. The repeated drops in oxygen set off a chain reaction: surges in stress hormones, oxidative damage to blood vessel walls, and structural changes in the heart itself.27PubMed. Sleep apnea is a common and dangerous cardiovascular risk factor People with severe sleep apnea face higher risks of coronary artery disease, heart failure, stroke, and dangerous heart rhythms, and these associations hold even after adjusting for the usual suspects like obesity, diabetes, and high blood pressure.28PubMed Central. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components Given how common undiagnosed sleep apnea is, especially in people who are already being treated for heart disease, it deserves more attention than it gets in routine checkups.
Gut Bacteria and TMAO
One of the more surprising avenues of cardiovascular research involves the gut microbiome. When you eat foods rich in certain nutrients, particularly choline and L-carnitine found in red meat, eggs, and some fish, gut bacteria convert them into a compound called trimethylamine. Your liver then transforms that into trimethylamine N-oxide (TMAO). Elevated TMAO has been linked to faster atherosclerosis, increased clot formation, and greater platelet clumping.29PubMed Central. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases There is growing interest in using TMAO as both a risk marker and a target for prevention, with research linking it to both coronary atherosclerosis and stroke.30PubMed Central. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide This line of research is still young, though, and nobody is recommending TMAO tests in routine clinical practice yet.
Social and Economic Factors
Biology does not operate in a vacuum. Where you live, how much money you earn, your access to healthcare, and the daily stresses you face all influence your likelihood of developing CVD and how well you fare once you have it. These social determinants of health affect the regional incidence of heart failure, readmission rates, access to advanced therapies, quality of care after a heart attack, and outcomes in conditions from atrial fibrillation to congenital heart disease.31PubMed Central. Impact of Social Determinants of Health on Cardiovascular Disease
These disparities are not subtle. Economic, environmental, and psychosocial factors play a significant role in the development of CVD risk factors as well as in cardiovascular sickness and death.32PubMed Central. Social Determinants of Cardiovascular Disease A person living in a neighborhood with limited access to fresh food, safe places to exercise, and affordable healthcare faces a steeper climb than someone with those resources available, even if their underlying biology is identical. Understanding CVD fully requires looking beyond cholesterol numbers.
Prevention and Statins
The shift from treating heart disease after it strikes to preventing it before it starts was one of the major paradigm changes in 20th-century medicine. The concept of a “risk factor” was itself popularized through the Framingham Heart Study, a long-running epidemiological project launched in 1948 that identified high blood pressure, high cholesterol, and diabetes as key predictors of future cardiovascular events.33PubMed Central. The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective
Today, the most widely studied preventive medication is the statin. A major Cochrane review pooling data from many randomized trials found that statins reduced overall death by about 14%, combined cardiovascular events by about 25%, and stroke by about 22% in people without prior cardiovascular disease. Rates of procedures to reopen blocked arteries also dropped significantly, and the review found no evidence of serious harm.34PubMed Central. Statins for the primary prevention of cardiovascular disease Cost-effectiveness analyses have suggested that lowering the risk threshold at which doctors offer statins could bring these benefits to a wider group at a reasonable cost per quality-adjusted life year gained.7PubMed Central. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
Statins are only one piece, though. Managing blood pressure, staying physically active, not smoking, controlling blood sugar, and maintaining a healthy weight remain the foundation. Medications can help, but they work best layered on top of those habits.
When Cancer Treatment Affects the Heart
A less commonly discussed contributor to cardiovascular disease is cancer treatment itself. Certain chemotherapy drugs can damage the heart muscle, with effects ranging from mild blood pressure changes and rhythm disturbances to full-blown heart failure. Some damage is permanent, while some reverses once treatment stops.35PubMed Central. Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management Radiation therapy to the chest, used for cancers like lymphoma and breast cancer, can also cause a range of heart complications that may not surface for years or even decades after treatment.36PubMed Central. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology
This has given rise to the field of cardio-oncology, which focuses on monitoring and protecting the hearts of cancer patients during and after treatment. If you or someone you know is a cancer survivor, particularly someone who received chest radiation or certain types of chemotherapy, long-term cardiovascular monitoring is worth discussing with a doctor. The heart complications may be delayed by many years, and catching them early changes the trajectory considerably.
The Scale of the Problem Ahead
Despite everything we know about prevention, CVD is projected to get worse globally before it gets better. Modeling estimates project a 90% increase in cardiovascular disease prevalence between 2025 and 2050, with deaths expected to climb from about 20.5 million to roughly 35.6 million per year.37PubMed. Global burden of cardiovascular diseases: projections from 2025 to 2050 Population aging, rising rates of obesity and diabetes, and uneven access to preventive care in low- and middle-income countries are all driving those numbers upward. The science of cardiovascular disease is more advanced than ever, but the gap between what we know and what we actually do about it continues to widen.